Gastroenterology Associates, PC, Offers Patients Access to Clinical Research
Gainesville, Va., Jan. 24, 2018 (Business Wire)-Gastroenterology Associates, PC, a gastroenterology practice with offices in Gainesville, Manassas and Warrenton, will begin providing clinical research services by partnering with Elligo Health Research, who improves clinical trial access by engaging the 97 percent of physicians currently not offering clinical research to their patients. By offering clinical trials as an option, the physicians at Gastroenterology Associates are able to introduce the latest advances in research to their patients. As a result, the practice’s patients have access - in the convenience of the physician’s office - to treatments they might not otherwise have. “To ensure we have better medicines and treatments for future generations, we need to have clinical research now,” said Scott Choi, M.D., of Gastroenterology Associates, PC. “With Elligo providing the framework, our practice can tap into this research to provide more treatment options for our patients. We look forward to being a part of the Elligo network.” “Our team at Elligo is excited to work with Gastroenterology Associates to advance the care its physicians offer to patients,” said John Potthoff, Ph.D., co-founder and CEO of Elligo Health Research. “By providing the personnel, processes, technology and infrastructure to make the clinical research process easier for practices at no cost, these practices like Gastroenterology Associates can remain focused on what they do best - taking care of patients.” About Gastroenterology Associates, PC Gastroenterology Associates has proudly served patients in Northern Virginia since 1976. As leading gastroenterologists in our area, all board certified, we are dedicated to helping our patients maintain good digestive health and to providing them the individual attention they deserve. We provide care to patients in an outpatient setting, as well as care for them or their loved ones, when they are hospitalized. Our long-standing reputation with the community offers patients the reliability and trustworthiness needed to feel secure with their medical decisions. CONTACT: Lea Studer SCORR Marketing 402-366-1752 lea@scorrmarketing.com
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
